Advertisement
Research Article

Retinoic Acid Signalling Is Activated in the Postischemic Heart and May Influence Remodelling

  • Dusan Bilbija mail,

    dusan.bilbija@medisin.uio.no

    Affiliations: Department of Physiology, University of Oslo, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway

    X
  • Fred Haugen,

    Affiliations: Department of Physiology, University of Oslo, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway

    X
  • Julia Sagave,

    Affiliations: Department of Physiology, University of Oslo, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway

    X
  • Anton Baysa,

    Affiliations: Department of Physiology, University of Oslo, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway

    X
  • Nasser Bastani,

    Affiliation: Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway

    X
  • Finn Olav Levy,

    Affiliations: Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway

    X
  • Allan Sirsjö,

    Affiliation: Division of Biomedicine, Department of Clinical Medicine, Örebro University, Örebro, Sweden

    X
  • Rune Blomhoff,

    Affiliation: Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway

    X
  • Guro Valen

    Affiliations: Department of Physiology, University of Oslo, Oslo, Norway, Center for Heart Failure Research, University of Oslo, Oslo, Norway

    X
  • Published: September 28, 2012
  • DOI: 10.1371/journal.pone.0044740

About the Authors

Dusan Bilbija, Fred Haugen, Julia Sagave, Anton Baysa, Guro Valen
Department of Physiology, University of Oslo, Oslo, Norway
Nasser Bastani, Rune Blomhoff
Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
Finn Olav Levy
Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Dusan Bilbija, Fred Haugen, Julia Sagave, Anton Baysa, Finn Olav Levy, Guro Valen
Center for Heart Failure Research, University of Oslo, Oslo, Norway
Allan Sirsjö
Division of Biomedicine, Department of Clinical Medicine, Örebro University, Örebro, Sweden

Corresponding Author

Email: dusan.bilbija@medisin.uio.no

Competing Interests

This study was partly funded by Freia Chocolate Factory’s Medical Fund. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Author Contributions

Conceived and designed the experiments: DB GV. Performed the experiments: DB FH JS NB. Analyzed the data: DB FH GV. Contributed reagents/materials/analysis tools: DB FOL AS RB GV. Wrote the paper: DB. Contributed with theoretical discussion: DB FH AB FOL AS RB GV.